Envestnet Asset Management Inc Trans Medics Group, Inc. Transaction History

Envestnet Asset Management Inc

$302 Billion
Q3 2024

A detailed history of Envestnet Asset Management Inc transactions in Trans Medics Group, Inc. stock. As of the latest transaction made, Envestnet Asset Management Inc holds 90,283 shares of TMDX stock, worth $7.27 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

90,283

Previous 74,724 20.82%

Holding current value

$7.27 Million

Previous $11.3 Million 25.95%

% of portfolio

0.0%

Previous 0.0%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 06, 2024	BUY	$135.68 - $176.11 $2.11 Million - $2.74 Million	15,559 Added 20.82%	90,283 $14.2 Million
Q2 2024 Aug 08, 2024	SELL	$72.62 - $150.62 $808,333 - $1.68 Million	-11,131 Reduced 12.96%	74,724 $11.3 Million
Q1 2024 May 13, 2024	SELL	$70.86 - $89.93 $757,918 - $961,891	-10,696 Reduced 11.08%	85,855 $6.35 Million
Q4 2023 Feb 13, 2024	BUY	$36.74 - $81.08 $580,455 - $1.28 Million	15,799 Added 19.56%	96,551 $7.62 Million
Q3 2023 Nov 13, 2023	BUY	$53.47 - $96.07 $2.2 Million - $3.96 Million	41,168 Added 104.0%	80,752 $4.42 Million
Q2 2023 Aug 04, 2023	BUY	$66.23 - $88.73 $584,810 - $783,485	8,830 Added 28.71%	39,584 $3.32 Million
Q1 2023 May 11, 2023	BUY	$53.63 - $82.33 $135,254 - $207,636	2,522 Added 8.93%	30,754 $2.33 Million
Q4 2022 Feb 07, 2023	SELL	$39.08 - $64.29 $309,787 - $509,626	-7,927 Reduced 21.92%	28,232 $1.74 Million
Q3 2022 Nov 10, 2022	SELL	$31.56 - $55.75 $668,188 - $1.18 Million	-21,172 Reduced 36.93%	36,159 $1.51 Million
Q2 2022 Aug 03, 2022	SELL	$20.56 - $32.15 $192,955 - $301,727	-9,385 Reduced 14.07%	57,331 $1.8 Million
Q1 2022 May 04, 2022	BUY	$12.58 - $26.94 $156,998 - $336,211	12,480 Added 23.01%	66,716 $1.8 Million
Q4 2021 Feb 04, 2022	BUY	$19.16 - $32.68 $18,182 - $31,013	949 Added 1.78%	54,236 $1.04 Million
Q3 2021 Oct 07, 2021	BUY	$25.92 - $34.51 $148,184 - $197,293	5,717 Added 12.02%	53,287 $1.76 Million
Q2 2021 Aug 04, 2021	SELL	$21.63 - $40.07 $8,760 - $16,228	-405 Reduced 0.84%	47,570 $1.58 Million
Q1 2021 May 04, 2021	BUY	$17.75 - $47.82 $187,599 - $505,409	10,569 Added 28.25%	47,975 $1.99 Million
Q4 2020 Feb 02, 2021	BUY	$11.91 - $19.9 $174,588 - $291,714	14,659 Added 64.44%	37,406 $744,000
Q3 2020 Oct 09, 2020	BUY	$13.78 - $18.84 $8,653 - $11,831	628 Added 2.84%	22,747 $313,000
Q2 2020 Jul 08, 2020	SELL	$11.66 - $18.26 $12,616 - $19,757	-1,082 Reduced 4.66%	22,119 $396,000
Q1 2020 Apr 23, 2020	BUY	$10.5 - $20.2 $39,333 - $75,669	3,746 Added 19.25%	23,201 $280,000
Q4 2019 Feb 11, 2020	BUY	$16.61 - $21.64 $323,147 - $421,006	19,455 New	19,455 $370,000

Others Institutions Holding TMDX

# of Institutions

394

Shares Held

31.9M

Call Options Held

466K

Put Options Held

286K

View Full List

About TransMedics Group, Inc.

Ticker TMDX
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 31,831,400
Market Cap $2.56B
Description
TransMedics Group, Inc., a commercial-stage medical technology company, engages in transforming organ transplant therapy for end-stage organ failure patients in the United States and internationally. The company offers Organ Care System (OCS), a portable organ perfusion, optimization, and monitoring system that utilizes its proprietary and custo...

More about TMDX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Envestnet Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Envestnet Asset Management Inc with notifications on news.

Account

Envestnet Asset Management Inc Trans Medics Group, Inc. Transaction History